DK243388A - Ekspression af fremmede gener i drosophila-celler - Google Patents

Ekspression af fremmede gener i drosophila-celler

Info

Publication number
DK243388A
DK243388A DK243388A DK243388A DK243388A DK 243388 A DK243388 A DK 243388A DK 243388 A DK243388 A DK 243388A DK 243388 A DK243388 A DK 243388A DK 243388 A DK243388 A DK 243388A
Authority
DK
Denmark
Prior art keywords
foreign genes
expression
drosophila cells
drosophila
cells
Prior art date
Application number
DK243388A
Other languages
English (en)
Other versions
DK175595B1 (da
DK243388D0 (da
Inventor
Hanne Ranch Johansen
Martin Rosenberg
Der Straten-Ponthoz Ariane Van
Original Assignee
Smithkline Beckman Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beckman Corp filed Critical Smithkline Beckman Corp
Publication of DK243388D0 publication Critical patent/DK243388D0/da
Publication of DK243388A publication Critical patent/DK243388A/da
Application granted granted Critical
Publication of DK175595B1 publication Critical patent/DK175595B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—RNA viruses
    • C07K16/112—Retroviridae (F), e.g. leukemia viruses
    • C07K16/114—Lentivirus (G), e.g. human immunodeficiency virus [HIV], feline immunodeficiency virus [FIV] or simian immunodeficiency virus [SIV]
    • C07K16/1145—Env proteins, e.g. gp41, gp110/120, gp160, V3, principal neutralising domain [PND] or CD4-binding site
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • C12N9/6459—Plasminogen activators t-plasminogen activator (3.4.21.68), i.e. tPA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21069—Protein C activated (3.4.21.69)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/90—Vectors containing a transposable element
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/001—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination
    • C12N2830/002—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination inducible enhancer/promoter combination, e.g. hypoxia, iron, transcription factor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/75—Vector systems having a special element relevant for transcription from invertebrates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Plant Pathology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK198802433A 1987-05-08 1988-05-04 Ekspression af fremmede gener i Drosophila-celler DK175595B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4773687A 1987-05-08 1987-05-08
US4773687 1987-05-08

Publications (3)

Publication Number Publication Date
DK243388D0 DK243388D0 (da) 1988-05-04
DK243388A true DK243388A (da) 1988-11-09
DK175595B1 DK175595B1 (da) 2004-12-13

Family

ID=21950656

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198802433A DK175595B1 (da) 1987-05-08 1988-05-04 Ekspression af fremmede gener i Drosophila-celler

Country Status (12)

Country Link
EP (1) EP0290261B1 (da)
JP (1) JP2706260B2 (da)
AT (1) ATE90969T1 (da)
AU (1) AU618952B2 (da)
CA (1) CA1341345C (da)
CY (1) CY1929A (da)
DE (1) DE3881953T2 (da)
DK (1) DK175595B1 (da)
ES (1) ES2058274T3 (da)
IE (1) IE63005B1 (da)
PT (1) PT87424B (da)
ZA (1) ZA883213B (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01108995A (ja) * 1987-10-23 1989-04-26 Hoechst Japan Kk 培養動物細胞による蛋白質の産生を向上させるための遺伝子増幅方法
CA2003794C (en) * 1988-12-01 2000-02-08 Hanne R. Johansen Expression of hiv proteins in drosophila cells
JPH03504082A (ja) * 1988-12-21 1991-09-12 スミスクライン・バイオロジカルズ 昆虫細胞によるプラスモディウム属サーカムスポロゾイト蛋白の発現

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR79202B (da) * 1982-05-05 1984-10-22 Genentech Inc
AU572108B2 (en) * 1983-01-19 1988-05-05 Genentech Inc. Human tpa production using vectors coding for dhfr protein
AU593264B2 (en) * 1985-07-10 1990-02-08 Kanegafuchi Kagaku Kogyo Kabushiki Kaisha Chromosomal DNA sequence, expression vector for human tissue plasminogen activating factor, cultured cells transfected with same and method of producing said activating factor
JP2515299B2 (ja) * 1986-06-03 1996-07-10 三井東圧化学株式会社 ヒ−トシヨツクたんぱく質遺伝子ｈｓｐ８３を含む発現ベクタ−及びこれを用いる誘導的発現

Also Published As

Publication number Publication date
JPS63304982A (ja) 1988-12-13
EP0290261B1 (en) 1993-06-23
DE3881953D1 (de) 1993-07-29
PT87424A (pt) 1989-05-31
AU618952B2 (en) 1992-01-16
DK175595B1 (da) 2004-12-13
ES2058274T3 (es) 1994-11-01
IE63005B1 (en) 1995-03-22
ZA883213B (en) 1989-03-29
DK243388D0 (da) 1988-05-04
CY1929A (en) 1997-05-16
AU1551088A (en) 1988-11-10
EP0290261A1 (en) 1988-11-09
IE881373L (en) 1988-11-08
HK1006852A1 (en) 1999-03-19
JP2706260B2 (ja) 1998-01-28
DE3881953T2 (de) 1993-09-30
CA1341345C (en) 2002-03-05
PT87424B (pt) 1992-09-30
ATE90969T1 (de) 1993-07-15

Similar Documents

Publication Publication Date Title
ES2061512T3 (es) Polipeptidos de nor-estatina y nor-cicloestatina.
DE3852714D1 (de) Oligodesoxynukleotide als Inhibitoren der Replikation von Retroviren und der Expression von Onkogenen.
DE3750755D1 (de) Anti-sense-Regulierung von Genexpression in Pflanzenzellen.
DE69020107D1 (de) Herstellung von peroxid enthaltenden perfluorpolyäthern.
FI862756A0 (fi) Fibroektiner.
DE69433168D1 (de) In vitro vermehrung von stammzellen
ATE187491T1 (de) Isolierung, selektion und vermehrung von tierischen transgen-stammzellen
DE58903288D1 (de) Verwendung von perfluoralkylgruppen aufweisenden (meth-)acrylsaeureestern in der dentaltechnik.
FI943122A0 (fi) Menetelmiä trombiinin tuottamiseksi
DE3785132D1 (de) Herstellung optisch aktiver cyclopropancarbonsaeuren.
DE69014298D1 (de) Stabilisierung von wasserstoffperoxydlösungen.
DK243388A (da) Ekspression af fremmede gener i drosophila-celler
DK636888A (da) Maalrettet inkorporering af gener i plantegenomer
NO870614D0 (no) Rask dna-paavisning av mikrober.
DK345087A (da) Modificeret vaevsplasminogenaktivator
DE3676604D1 (de) Expression von epa in saeugetierzellen.
FI902239A0 (fi) Nya maennskavaevnadsliknande plasminogen aktivator variant.
DE3888505D1 (de) Herstellung von Zimtsäureestern.
NO912099L (no) Ekspresjon av hiv-proteiner i drosophilia-celler.
DE3768542D1 (de) Herstellung von zimtsaeureestern.
IT8619669A0 (it) Procedimento per il trattamento di acque reflue derivanti dalla tintura in linea di fibre acriliche.
ATE29734T1 (de) Verwendung von salicylsaeureestern als riechstoffe und diese enthaltende riechstoffkompositionen.
ATE46921T1 (de) Verbesserungen in der expression von neu eingefuehrten genen in hefezellen.
KR850003168A (ko) 해태의 세포 융합 방법
ATE86292T1 (de) Verwendung von monocarbonsaeurepolyoxyalkylester - sulfonaten als schaumarme textilbehandlungsmittel.

Legal Events

Date Code Title Description
PUP Patent expired